P 5 Heterogeneity in major cardiovascular events assessment between countries participating in an international collaboration of 20 registers of rheumatoid arthritis patients using Janus Kinase Inhibitors (the "JAK-pot" study)

R Guemara; R Aymon; J Askling; SA Bergstra; D Choquette; C Codreanu; RL Cordtz; E Dalkilic; D De Cock; L Dreyer; O Elkayam; D Huscheck; KL Hyrich; F Iannone; N Inanc; L Kearsley-Fleet; TK Kvien; B Leeb; G Lukina; D Nordström; K Pavelka; M Pombo-Suarez; SA Provan; AM Rodrigues; Z Rotar; A Strangfeld; P Verschueren; J Zavada; D Courvoisier; A Finckh; D Mongin; K Lauper

doi:10.57187/smw.2023.40135

P 5 Heterogeneity in major cardiovascular events assessment between countries participating in an international collaboration of 20 registers of rheumatoid arthritis patients using Janus Kinase Inhibitors (the "JAK-pot" study)

R Guemara, R Aymon, J Askling, SA Bergstra, D Choquette, C Codreanu, RL Cordtz, E Dalkilic, D De Cock, L Dreyer, O Elkayam, D Huscheck, KL Hyrich, F Iannone, N Inanc, L Kearsley-Fleet, TK Kvien, B Leeb, G Lukina, D NordströmK Pavelka, M Pombo-Suarez, SA Provan, AM Rodrigues, Z Rotar, A Strangfeld, P Verschueren, J Zavada, D Courvoisier, A Finckh, D Mongin, K Lauper

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	6S-7S
Number of pages	2
Journal	Swiss Medical Weekly
Volume	153
Issue number	8 S271
DOIs	https://doi.org/10.57187/smw.2023.40135
Publication status	Published - 28 Aug 2023
Event	Annual meeting of the Swiss Society of Rheumatology 2023 - Interlaken, Switzerland Duration: 31 Aug 2023 → 1 Sept 2023

Access to Document

10.57187/smw.2023.40135Licence: CC BY

Cite this

Guemara, R., Aymon, R., Askling, J., Bergstra, SA., Choquette, D., Codreanu, C., Cordtz, RL., Dalkilic, E., De Cock, D., Dreyer, L., Elkayam, O., Huscheck, D., Hyrich, KL., Iannone, F., Inanc, N., Kearsley-Fleet, L., Kvien, TK., Leeb, B., Lukina, G., ... Lauper, K. (2023). P 5 Heterogeneity in major cardiovascular events assessment between countries participating in an international collaboration of 20 registers of rheumatoid arthritis patients using Janus Kinase Inhibitors (the "JAK-pot" study). Swiss Medical Weekly, 153(8 S271), 6S-7S. https://doi.org/10.57187/smw.2023.40135

@article{e5c845ccd4ff41cbb8bf6898532ce9ea,

title = "P 5 Heterogeneity in major cardiovascular events assessment between countries participating in an international collaboration of 20 registers of rheumatoid arthritis patients using Janus Kinase Inhibitors (the {"}JAK-pot{"} study)",

author = "R Guemara and R Aymon and J Askling and SA Bergstra and D Choquette and C Codreanu and RL Cordtz and E Dalkilic and {De Cock}, D and L Dreyer and O Elkayam and D Huscheck and KL Hyrich and F Iannone and N Inanc and L Kearsley-Fleet and TK Kvien and B Leeb and G Lukina and D Nordstr{\"o}m and K Pavelka and M Pombo-Suarez and SA Provan and AM Rodrigues and Z Rotar and A Strangfeld and P Verschueren and J Zavada and D Courvoisier and A Finckh and D Mongin and K Lauper",

year = "2023",

month = aug,

day = "28",

doi = "10.57187/smw.2023.40135",

language = "English",

volume = "153",

pages = "6S--7S",

journal = "Swiss Medical Weekly",

issn = "1424-7860",

publisher = "EMH Swiss Medical Publishers Ltd",

number = "8 S271",

note = "Annual meeting of the Swiss Society of Rheumatology 2023 ; Conference date: 31-08-2023 Through 01-09-2023",

}

Guemara, R, Aymon, R, Askling, J, Bergstra, SA, Choquette, D, Codreanu, C, Cordtz, RL, Dalkilic, E, De Cock, D, Dreyer, L, Elkayam, O, Huscheck, D, Hyrich, KL, Iannone, F, Inanc, N, Kearsley-Fleet, L, Kvien, TK, Leeb, B, Lukina, G, Nordström, D, Pavelka, K, Pombo-Suarez, M, Provan, SA, Rodrigues, AM, Rotar, Z, Strangfeld, A, Verschueren, P, Zavada, J, Courvoisier, D, Finckh, A, Mongin, D & Lauper, K 2023, 'P 5 Heterogeneity in major cardiovascular events assessment between countries participating in an international collaboration of 20 registers of rheumatoid arthritis patients using Janus Kinase Inhibitors (the "JAK-pot" study)', Swiss Medical Weekly, vol. 153, no. 8 S271, pp. 6S-7S. https://doi.org/10.57187/smw.2023.40135

P 5 Heterogeneity in major cardiovascular events assessment between countries participating in an international collaboration of 20 registers of rheumatoid arthritis patients using Janus Kinase Inhibitors (the "JAK-pot" study). / Guemara, R; Aymon, R; Askling, J et al.
In: Swiss Medical Weekly, Vol. 153, No. 8 S271, 28.08.2023, p. 6S-7S.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - P 5 Heterogeneity in major cardiovascular events assessment between countries participating in an international collaboration of 20 registers of rheumatoid arthritis patients using Janus Kinase Inhibitors (the "JAK-pot" study)

AU - Guemara, R

AU - Aymon, R

AU - Askling, J

AU - Bergstra, SA

AU - Choquette, D

AU - Codreanu, C

AU - Cordtz, RL

AU - Dalkilic, E

AU - De Cock, D

AU - Dreyer, L

AU - Elkayam, O

AU - Huscheck, D

AU - Hyrich, KL

AU - Iannone, F

AU - Inanc, N

AU - Kearsley-Fleet, L

AU - Kvien, TK

AU - Leeb, B

AU - Lukina, G

AU - Nordström, D

AU - Pavelka, K

AU - Pombo-Suarez, M

AU - Provan, SA

AU - Rodrigues, AM

AU - Rotar, Z

AU - Strangfeld, A

AU - Verschueren, P

AU - Zavada, J

AU - Courvoisier, D

AU - Finckh, A

AU - Mongin, D

AU - Lauper, K

PY - 2023/8/28

Y1 - 2023/8/28

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:001059245500008&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.57187/smw.2023.40135

DO - 10.57187/smw.2023.40135

M3 - Meeting Abstract

SN - 1424-7860

VL - 153

SP - 6S-7S

JO - Swiss Medical Weekly

JF - Swiss Medical Weekly

IS - 8 S271

T2 - Annual meeting of the Swiss Society of Rheumatology 2023

Y2 - 31 August 2023 through 1 September 2023

ER -

Guemara R, Aymon R, Askling J, Bergstra SA, Choquette D, Codreanu C et al. P 5 Heterogeneity in major cardiovascular events assessment between countries participating in an international collaboration of 20 registers of rheumatoid arthritis patients using Janus Kinase Inhibitors (the "JAK-pot" study). Swiss Medical Weekly. 2023 Aug 28;153(8 S271):6S-7S. doi: 10.57187/smw.2023.40135

P 5 Heterogeneity in major cardiovascular events assessment between countries participating in an international collaboration of 20 registers of rheumatoid arthritis patients using Janus Kinase Inhibitors (the "JAK-pot" study)

Access to Document

Other files and links

Cite this